Published on
Jun 28, 2022
Lily-Incyte pill for severe hair loss disease gets FDA approval
Eli Lilly and Company and Incyte announced that the U.S. Food and Drug Administration (FDA) has approved Olumiant (baricitinib), a once-daily pill, as a first-in-disease systemic treatment for adults with severe alopecia areata. “People with alopecia …
Source:
Delaware Business Now
-
Neutral
